Therapeutic compositions
A compound, hydroxybutyric acid technology, used in drug combinations, food ingredients containing organic compounds, food science, etc., can solve the problems of reducing leucine oxidation, ineffectiveness, hypertriglyceridemia, etc.
Inactive Publication Date: 2010-11-10
BRITISH TECH GRP LTD
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Fourth, the consumption of large amounts of lipid substances in adults can lead to severe hypertriglyceridemia, the pathological consequence of which is an increased risk of vascular disease, sporadic liver disease, and pancreatic disease, so lipids cannot be prescribed in the medical field use
It was found to be non-toxic and reduced the concentration of glucose free fatty acids and glycerol, but had no effect on reducing the oxidation of leucine
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Property | Measurement | Unit |
---|---|---|
melting point | aaaaa | aaaaa |
optical rotation | aaaaa | aaaaa |
melting point | aaaaa | aaaaa |
Login to View More
Abstract
Compositions comprising ketone bodies and / or their metabolic precursors are provided that are suitable for administration to humans and animals and which have the properties of, inter alia, (i) increasing cardiac efficiency, particularly efficiency in use of glucose, (ii) for providing energy source, particularly in diabetes and insulin resistant states and (iii) treating disorders caused by damage to brain cells, particularly by retarding or preventing brain damage in memory associated brain areas such as found in Alzheimer's and similar conditions.These compositions may be taken as nutritional aids, for example for athletes, or for the treatment of medical conditions, particularly those associated with poor cardiac efficiency, insulin resistance and neuronal damage. The invention further provides methods of treatment and novel esters and polymers for inclusion in the compositions of the invention.
Description
therapeutic composition This application is a divisional application of a Chinese patent application with a priority date of March 17, 1997, an application date of March 17, 1998, and application number 98805163.X. technical field The present invention relates to compositions suitable for administration to humans and animals, characterized in particular by (i) enhancing cardiac performance, especially the efficiency with which the heart utilizes glucose, (ii) providing energy, especially in diabetes and insulin resistance (iii) treating conditions caused by damage to brain cells, especially by delaying or preventing brain damage in areas of the brain associated with memory, such as in the brain in Alzheimer's disease and similar conditions Find the brain damage, to achieve the therapeutic effect. These compositions can be used as nutritional supplements, for example for athletes, or for the treatment of diseases, especially those related to cardiac insufficiency, insulin re...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/22A61K31/225A61K31/19A61P25/08A61P3/10A61P5/50A23L1/30A23L33/00A61K31/121A61K31/765A61P9/00A61P25/00A61P43/00C07C59/10C08G63/06
CPCC08G63/06A61K31/22A23L1/293A61K31/765A23V2002/00A23L1/30A23L33/10A23L33/30A61P3/00A61P3/10A61P5/50A61P9/00A61P25/00A61P25/02A61P25/08A61P25/16A61P25/28A61P43/00A23V2250/30A61K31/19
Inventor R·L·韦奇
Owner BRITISH TECH GRP LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com